These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12843899)

  • 1. [Combining artificial tears---are they always synergistic?].
    Bury T; Bourcier T; Debbasch C; Laroche L
    J Fr Ophtalmol; 2003 Apr; 26(4):396-9. PubMed ID: 12843899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study.
    Amrane M; Creuzot-Garcher C; Robert PY; Ismail D; Garrigue JS; Pisella PJ; Baudouin C
    J Fr Ophtalmol; 2014 Oct; 37(8):589-98. PubMed ID: 25127703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of 0.15% sodium hyaluronate versus polyvinyl alcohol in the treatment of dry eyes].
    Vico E; Quereda A; Benítez-Del-Castillo JM; Fernández C; García-Sánchez J
    Arch Soc Esp Oftalmol; 2005 Jul; 80(7):387-94. PubMed ID: 16059815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness, tolerance and acceptance of polyvidon preparations].
    Höh H; Fink R; Dehnicke C; Klöcker N
    Klin Monbl Augenheilkd; 1999 Oct; 215(4):A8-14. PubMed ID: 10572880
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye.
    Cömez AT; Tufan HA; Kocabıyık O; Gencer B
    Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, double-blind, parallel group, placebo-controlled clinical study to examine the safety and efficacy of T-Clair SPHP700-3 in the management of mild to moderate dry eye in adults.
    Villani E; Laganovska G; Viola F; Pirondini C; Baumane K; Radecka L; Ratiglia R
    Cornea; 2011 Mar; 30(3):265-8. PubMed ID: 21099417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritation associated with tear-replacement ophthalmic drops. A pharmaceutical and subjective investigation.
    Fassihi AR; Naidoo NT
    S Afr Med J; 1989 Mar; 75(5):233-5. PubMed ID: 2648609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is there an universal artificial tear?].
    Turu L
    Oftalmologia; 2012; 56(1):14-9. PubMed ID: 22888681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients.
    Papa V; Aragona P; Russo S; Di Bella A; Russo P; Milazzo G
    Ophthalmologica; 2001; 215(2):124-7. PubMed ID: 11244343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
    Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness.
    Scaffidi RC; Korb DR
    Eye Contact Lens; 2007 Jan; 33(1):38-44. PubMed ID: 17224677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.
    Ousler GW; Michaelson C; Christensen MT
    Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of local acetylcysteine and artificial tears in the management of dry eye syndrome].
    Pokupec R; Petricek I; Sikić J; Bradić M; Popović-Suić S; Petricek G
    Acta Med Croatica; 2005; 59(4):337-40. PubMed ID: 16334742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine 0.09% solution (Cequa) for dry eye Disease.
    Med Lett Drugs Ther; 2019 Jul; 61(1577):116-118. PubMed ID: 31381551
    [No Abstract]   [Full Text] [Related]  

  • 18. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.
    Rao SN
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):603-9. PubMed ID: 21999340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slitlamp biomicroscopy of the tear film of patients using topical Restasis and Refresh Endura.
    Solomon R; Perry HD; Donnenfeld ED; Greenman HE
    J Cataract Refract Surg; 2005 Apr; 31(4):661-3. PubMed ID: 15899439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.